Pharma Journalist - Page 97 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

Granite Bio Debuts With $100 Million of Capital

Regeneron Invests in Expanding Biologic Medicine Manufacturing

Boehringer Ingelheim and Tessellate Bio Partner on Precision Treatments for Hard-to-Treat Cancers

ConcertAI Partners with Bayer to Advance Precision Oncology Clinical Development

Ono and Jorna Launch Collaboration on Novel RNA Editing Therapies

Roche to Invest $50B in U.S. Pharma and Diagnostics Over 5 Years

uniQure’s AMT-130 Gets FDA Breakthrough Tag for Huntington’s

DAAN Biotherapeutics and GC Cell Sign Deal to Transfer Tumor Antigen Antibody Tech for Next-Gen CAR-T/NK Therapies

Dupixent Approved in U.S. as First Targeted Therapy in Over a Decade for Chronic Hives

BigHat and Lilly Team Up to Develop AI-Driven Antibody Therapies